Atria Wealth Solutions’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.21M Sell
11,385
-27,644
-71% -$7.83M 0.07% 298
2025
Q1
$12.2M Sell
39,029
-6,724
-15% -$1.99M 0.15% 150
2024
Q4
$11.9M Buy
45,753
+1,451
+3% +$431K 0.13% 163
2024
Q3
$14.3M Sell
44,302
-1,078
-2% -$353K 0.15% 136
2024
Q2
$14.2M Sell
45,380
-1,118
-2% -$328K 0.16% 136
2024
Q1
$13.2M Buy
46,498
+414
+0.9% +$121K 0.15% 148
2023
Q4
$13.3M Sell
46,084
-489
-1% -$133K 0.17% 130
2023
Q3
$12.5M Sell
46,573
-225
-0.5% -$56.1K 0.18% 126
2023
Q2
$10.4M Buy
46,798
+413
+0.9% +$95.8K 0.14% 148
2023
Q1
$11.2M Buy
46,385
+351
+0.8% +$86.2K 0.17% 134
2022
Q4
$12.1M Sell
46,034
-1,106
-2% -$296K 0.19% 117
2022
Q3
$10.6M Buy
47,140
+10,486
+29% +$2.54M 0.18% 118
2022
Q2
$5.74M Buy
36,654
+95
+0.3% +$23.3K 0.11% 204
2022
Q1
$8.84M Buy
+36,559
New +$8.4M 0.15% 150

Other funds holding AMGN

Atria Wealth Solutions's AMGN Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Amgen (AMGN) stake by 71% in Q2 2025, selling an estimated $7.83M and leaving 11,385 shares worth $3.21M. The position accounts for 0.07% of the portfolio, ranked #298.

Atria Wealth Solutions first reported a position in AMGN in Q1 2022 and has held it in 14 quarters since. The position peaked at $14.3M in Q3 2024. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Atria Wealth Solutions held 11,385 shares of Amgen worth $3.21M as of Q2 2025.
  • Atria Wealth Solutions sold 27,644 Amgen shares in Q2 2025, an estimated $7.83M.
  • Amgen made up 0.07% of Atria Wealth Solutions's portfolio in Q2 2025, its #298 holding.
  • Atria Wealth Solutions first reported a position in Amgen in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Amgen position peaked at $14.3M in Q3 2024.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.